G
Garrett E. Schramm
Researcher at Mayo Clinic
Publications - 26
Citations - 1480
Garrett E. Schramm is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Septic shock & Pharmacy. The author has an hindex of 13, co-authored 26 publications receiving 1325 citations. Previous affiliations of Garrett E. Schramm include Barnes-Jewish Hospital.
Papers
More filters
Journal ArticleDOI
The Importance of Fluid Management in Acute Lung Injury Secondary to Septic Shock
Claire V. Murphy,Garrett E. Schramm,Joshua A. Doherty,Richard M. Reichley,Ognjen Gajic,Bekele Afessa,Scott T. Micek,Marin H. Kollef +7 more
TL;DR: Both early and late fluid management of septic shock complicated by ALI can influence patient outcomes.
Journal ArticleDOI
Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria
Katherine E. Kollef,Garrett E. Schramm,Angela R. Wills,Richard M. Reichley,Scott T. Micek,Marin H. Kollef +5 more
TL;DR: It is suggested that inappropriate initial antibiotic therapy of microbiologically confirmed VAP attributed to PARGNB is associated with greater 30-day mortality and total hospitalization costs.
Journal ArticleDOI
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
Scott T. Micek,Richard G. Wunderink,Marin H. Kollef,Catherine Chen,Jordi Rello,Jean Chastre,Massimo Antonelli,Tobias Welte,Bernard Clair,Helmut Ostermann,Esther Calbo,Antoni Torres,Francesco Menichetti,Garrett E. Schramm,Vandana Menon +14 more
TL;DR: Among patients with Pa-NP the presence of infection with a MDR strain is associated with increased in-hospital mortality, and identification of patients at risk of MDR Pa- NP could facilitate appropriate empiric antibiotic decisions that could lead to improved hospital survival.
Journal ArticleDOI
Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment.
TL;DR: Inappropriate initial antimicrobial treatment of MRSA sterile-site infections is common and is associated with an increased risk of hospital mortality, and may be maximized by increased use of initial empirical antimicrobialtreatment regimens targeting MRSA in patients at risk for this infection until organism identification and susceptibility become known.
Journal ArticleDOI
Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality.
TL;DR: In septic shock, the activation of the sepsis response team in combination with weekly feedback increases the compliance with the process of care and reduces hospital mortality rate.